Found 5 matching trials
Extension Study of H01_04TP to Evaluate the Booster Response Induced by Vi-CRM197 in Adults
PHASE2The purpose of this study is to evaluate the immunogenicity and the kinetic...
Location
Centre for the Evaluation of Vaccination (CEV)
Safety and Immunogenicity of Three Formulations of Vi-CRM197 Vaccine Against S. Typhi in Adults (18-40 Years Old)
PHASE2This trial is aimed to evaluate the safety and immunogenicity profiles of t...
Location
Center for the Evaluation of Vaccination (CEV)
Safety and Immunogenicity of Vi-CRM197 Vaccine Against S. Typhi in Adult (18-40 Years Old)
PHASE1This trial is aimed to evaluate the safety and immunogenicity profiles of a...
Location
Center for the Evaluation of Vaccination (CEV)
Safety and Immunogenicity of Vi-CRM197 Vaccine Against S. Typhi in Children, Older Infants and Infants
PHASE2This phase 2 trial is aimed to obtain information on the safety and immunog...
Location
Research Institute for Tropical Medicine (RITM)
Safety and Immunogenicity of Vi-CRM197 Vaccine Against S. Typhi in Adults, Children, Older Infants and Infants
PHASE2This phase 2 trial is aimed to obtain information on the safety and immunog...
Location
K.E.M. Hospital Research Centre